Dose-dependent effects of the caspase inhibitor Q-VD-OPh on different apoptosis-related processes

Kateřina Kuželová1, Dana Grebeňová, Barbora Brodská

  • 1Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2, 128 20 Prague 2, Czech Republic. katerina.kuzelova@uhkt.cz

Insights

The pan-caspase inhibitor Q-VD-OPh effectively blocks caspase activity and DNA fragmentation at low concentrations. It also prevents PARP cleavage and preserves cell membrane integrity during apoptosis.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Apoptosis is a crucial biological process involving caspases.
  • Pan-caspase inhibitors are vital tools for studying apoptosis.
  • Q-VD-OPh is a potent inhibitor with potential therapeutic applications.

Purpose of the Study:

  • To comprehensively evaluate the efficacy of Q-VD-OPh in inhibiting various apoptotic markers.
  • To compare Q-VD-OPh with another pan-caspase inhibitor, z-VAD-fmk.
  • To investigate the dose-dependent effects of Q-VD-OPh on cellular processes during apoptosis.

Main Methods:

  • Analysis of caspase-3, -7, and -8 activity using fluorometric assays and immunoblots.
  • Assessment of Poly (ADP-ribose) polymerase (PARP-1) cleavage.
  • Evaluation of DNA fragmentation and cell membrane integrity (Trypan blue exclusion test).
  • Measurement of cellular adhesivity to fibronectin.
  • Utilized JURL-MK1 and HL60 cell lines with imatinib mesylate and suberoylanilide hydroxamic acid as apoptosis inducers.

Main Results:

  • Q-VD-OPh potently inhibited caspase-3 and -7 activity at 0.05 µM and caspase-8 at low concentrations.
  • Higher concentrations (10 µM) of Q-VD-OPh were required for complete PARP-1 cleavage inhibition.
  • DNA fragmentation and cell membrane dysfunction were prevented at 2 µM Q-VD-OPh.
  • Q-VD-OPh (10 µM) inhibited drug-induced loss of fibronectin adhesion in JURL-MK1 cells.
  • Mitochondrial antigen 7A6 exposition occurred independently of Q-VD-OPh, suggesting its use in detecting early apoptotic events.
  • Q-VD-OPh demonstrated significantly higher efficiency than z-VAD-fmk in inhibiting caspase-3 and DNA fragmentation.

Conclusions:

  • Q-VD-OPh is a highly effective pan-caspase inhibitor with superior potency compared to z-VAD-fmk.
  • Its efficacy spans multiple apoptotic pathways, including caspase activation, DNA fragmentation, and PARP cleavage.
  • Q-VD-OPh preserves cellular integrity and adhesion during apoptosis, highlighting its potential in therapeutic strategies targeting apoptotic processes.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...